Difference between revisions of "Team:Shenzhen SFLS/Model"

Line 85: Line 85:
 
             <img src="https://static.igem.org/mediawiki/2017/5/58/SFLS_2017_Modeling_V600E.png" width="500" alt="demonstrate-sequencing-ATCG">
 
             <img src="https://static.igem.org/mediawiki/2017/5/58/SFLS_2017_Modeling_V600E.png" width="500" alt="demonstrate-sequencing-ATCG">
 
           </div>
 
           </div>
 +
 +
<p>Fig. 2 The graphic of BRAF 1799T>A (V600E) mutation</p>
 +
 +
 +
 
           <br/><br/>
 
           <br/><br/>
 
           <p>In our project, we try to disrupt the mutant BRAF in the two melanoma cell lines (A375 and G361) by CRISPR/Cas9 technology. A typical PAM is ‘NGG’. However, we didn’t find it. It has been reported that alternative PAM sequence ‘NAG’ has rather high cleavage efficiency while ‘NTG’ shows no tendency of cutting (3). To meet the goal of specifical cleavage, we arranged the mutant base on the three PAM bases as shown in Fig 3.  </p>
 
           <p>In our project, we try to disrupt the mutant BRAF in the two melanoma cell lines (A375 and G361) by CRISPR/Cas9 technology. A typical PAM is ‘NGG’. However, we didn’t find it. It has been reported that alternative PAM sequence ‘NAG’ has rather high cleavage efficiency while ‘NTG’ shows no tendency of cutting (3). To meet the goal of specifical cleavage, we arranged the mutant base on the three PAM bases as shown in Fig 3.  </p>
Line 90: Line 95:
 
             <img src="https://static.igem.org/mediawiki/2017/7/7e/SFLS_2017_Modeling_target_region_%26_sgRNA.png" width="700" alt="demonstrate-sequencing-ATCG">
 
             <img src="https://static.igem.org/mediawiki/2017/7/7e/SFLS_2017_Modeling_target_region_%26_sgRNA.png" width="700" alt="demonstrate-sequencing-ATCG">
 
           </div>
 
           </div>
 +
 +
<p>Fig.3 The sgRNA for targeting mutant BRAf in melanoma cells</p>
 +
 
           <br/><br/>
 
           <br/><br/>
 
           <p>After setting the sgRNA sequence, we searched for the potential off-target locus. The potential off-target locus must meet the following conditions: 1) Having a PAM sequence (‘NGG’, ‘NAG’, ‘NCG’, or ‘NGA’) at 3’ end; 2) Base identities are more than 13 identified by <a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM =blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome">MegaBLAST</a>; 3) CFD score is greater than 5%.</p>
 
           <p>After setting the sgRNA sequence, we searched for the potential off-target locus. The potential off-target locus must meet the following conditions: 1) Having a PAM sequence (‘NGG’, ‘NAG’, ‘NCG’, or ‘NGA’) at 3’ end; 2) Base identities are more than 13 identified by <a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM =blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome">MegaBLAST</a>; 3) CFD score is greater than 5%.</p>
Line 108: Line 116:
 
             <img src="https://static.igem.org/mediawiki/2017/d/df/SFLS_2017_Modeling_potential_off_target_region.png" width="700" alt="demonstrate-sequencing-ATCG">
 
             <img src="https://static.igem.org/mediawiki/2017/d/df/SFLS_2017_Modeling_potential_off_target_region.png" width="700" alt="demonstrate-sequencing-ATCG">
 
           </div>
 
           </div>
 +
 +
<p>Fig.4 Potential off-target sites of our sgRNA. PAM is marked in red. Compared with the sgRNA, the different bases are marked in yellow.</p>
 
           <br/><br/>
 
           <br/><br/>
 
           <div class="picture">
 
           <div class="picture">
Line 115: Line 125:
  
 
         </div>
 
         </div>
 +
 +
<p>Fig.5 Proportion of active sgRNAs with different PAM (Data derived from Doench 2016)</p>
  
  
Line 126: Line 138:
  
 
         <div class="mainpage mainpage2" id="reference">
 
         <div class="mainpage mainpage2" id="reference">
           <h5 id="index_4">CONCLUSION</h5>
+
           <h5 id="index_4">Conclusion</h5>
 
           <p>Our sgRNA sequence has high cleavage efficiency on the mutated BRAF gene, as well as a high risk of off-target effect. To avoid the off-target effect, we designed an artificial microRNA complementary to SAMMSON gene, which is specifically expressed in human melanomas. The CRISPR/CAS9 system is only activated in cancer cells, no any effects on normal cells.</p>
 
           <p>Our sgRNA sequence has high cleavage efficiency on the mutated BRAF gene, as well as a high risk of off-target effect. To avoid the off-target effect, we designed an artificial microRNA complementary to SAMMSON gene, which is specifically expressed in human melanomas. The CRISPR/CAS9 system is only activated in cancer cells, no any effects on normal cells.</p>
 
         </div>
 
         </div>
 +
      <br/><br/><br/>
 +
 +
<h5 id="index_4">Reference</h5>
 +
<p>1. http://crispr.mit.edu/</p>
 +
<p>2. Stemmer M, Thumberger T, del Sol Keyer M, et al. CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLOS ONE, 2015, 10(4): e0124633.</p>
 +
<p>3. Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology, 2016, 34(2): 184-191.</p>
  
  

Revision as of 17:39, 30 October 2017

Team:Shenzhen SFLS/Demonstrate - 2017.igem.org

Team:Shenzhen SFLS/Demonstrate - 2017.igem.org

Modeling

INTRODUCTION

Since the CRISPR/Cas9 system wasfirstly used in genetic engineering, the researches on its off-target effects have never stopped. The methods of Hsu-Zhang scoring (1) and CCTop (2) are two widely used algorithms for designing a single guide RNA (sgRNA) sequence and finding potential off-target locus. Last year, a new algorithm named CFD (Cutting Frequency Determination) scoring method was developed to evaluate potential off-target sits with 240 parameters (Fig. 1) (3). All of these three methods (Hsu-Zhang scoring, CCTop, and CFD) take into consideration different weight coefficients of different mismatch position, however, only CFD scoring method considers mismatch types as a factor as well.

demonstrate_fig.1


demonstrate_fig.2


Fig.1 The values of CFD scores change over mismatch positions and types (Data derived from Doench 2016). Mismatch position is counted from 5’ end of gene, position 20 represent the nucleotide nearest to protospacer adjacent motif (PAM), and position 1 represent the nucleotide furthest from PAM.




Methods

We chose to use CFD scoring method instead of Hsu-Zhang scoring or CCTop for the following reasons: Firstly, it is reported that the CFD method has higher Pearson correlation (3), compared with Hsu-Zhang scoring method and CCTop, especially when the number of mismatched bases is large; Secondly, Computing the scores by using CFD method is much easier than the other two methods.

In order to obtain the CFD score of a certain DNA locus, we multiply all the scores of single base mismatch together. If the DNA loci and sgRNA has mismatched bases at position α, β, γ… with mismatch type rA-dC, rC-dC, rU-dT…(Fig. 1B), its CFD score is calculated as:

demonstrate-sequencing


It is reported that about 60% of melanomas contain a mutation in the v-raf murine sarcoma viral oncogene homolog B (BRAF), and V600E (1799T> A) variation (Fig. 2) in BRAF is the main type of mutations in the cancer tissues, which plays a critical role in carcinogenesis of melanoma.

demonstrate-sequencing-ATCG

Fig. 2 The graphic of BRAF 1799T>A (V600E) mutation



In our project, we try to disrupt the mutant BRAF in the two melanoma cell lines (A375 and G361) by CRISPR/Cas9 technology. A typical PAM is ‘NGG’. However, we didn’t find it. It has been reported that alternative PAM sequence ‘NAG’ has rather high cleavage efficiency while ‘NTG’ shows no tendency of cutting (3). To meet the goal of specifical cleavage, we arranged the mutant base on the three PAM bases as shown in Fig 3.

demonstrate-sequencing-ATCG

Fig.3 The sgRNA for targeting mutant BRAf in melanoma cells



After setting the sgRNA sequence, we searched for the potential off-target locus. The potential off-target locus must meet the following conditions: 1) Having a PAM sequence (‘NGG’, ‘NAG’, ‘NCG’, or ‘NGA’) at 3’ end; 2) Base identities are more than 13 identified by MegaBLAST; 3) CFD score is greater than 5%.




RESULTS

Using Megablast, we find that over 500 alignments have potential off-target effects, and 62 of them have a PAM sequence (‘NGG’, ‘NAG’, ‘NCG’, or ‘NGA’). Seven of them are scored higher than 5% (Fig. 4). As reported (3) that ‘NGG’ PAM has much higher efficiency of cleavage than ‘NAG’ (Fig.5), the off-target probability of Seq 2, 3, 4, 5, 6 and 7 may be higher than it scores.

demonstrate-sequencing-ATCG

Fig.4 Potential off-target sites of our sgRNA. PAM is marked in red. Compared with the sgRNA, the different bases are marked in yellow.



demonstrate-sequencing-ATCG


Fig.5 Proportion of active sgRNAs with different PAM (Data derived from Doench 2016)




Conclusion

Our sgRNA sequence has high cleavage efficiency on the mutated BRAF gene, as well as a high risk of off-target effect. To avoid the off-target effect, we designed an artificial microRNA complementary to SAMMSON gene, which is specifically expressed in human melanomas. The CRISPR/CAS9 system is only activated in cancer cells, no any effects on normal cells.




Reference

1. http://crispr.mit.edu/

2. Stemmer M, Thumberger T, del Sol Keyer M, et al. CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLOS ONE, 2015, 10(4): e0124633.

3. Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology, 2016, 34(2): 184-191.